help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlechte, J. A.
Right arrow Articles by Martin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlechte, J. A.
Right arrow Articles by Martin, R.

Journal of Clinical Endocrinology & Metabolism, Vol 56, 1120-1123, Copyright © 1983 by Endocrine Society


ARTICLES

Bone density in amenorrheic women with and without hyperprolactinemia

JA Schlechte, B Sherman and R Martin

To determine whether decreased bone density in patients with PRL- secreting pituitary tumors is specifically related to hyperprolactinemia or is a consequence of disordered pituitary-gonadal function common to all amenorrheic states, we measured the bone mineral content of the radius by photon absorptiometry in normal subjects, in women with amenorrhea and normal serum PRL levels, and in women with PRL-secreting pituitary tumors. The women did not differ significantly in mean age, height, weight, or serum calcium, phosphorous, gonadotropin, testosterone, vitamin D, or PTH concentrations, and all had normal renal and thyroid function. The bone mineral content in women with amenorrhea and normal serum PRL levels (0.91 +/- 0.02 g/cm) was not significantly different from that in control subjects (0.88 +/- 0.01 g/cm). Patients with PRL-secreting tumors studied 2-5 yr after transsphenoidal surgery had significantly diminished bone mineral content whether they were cured (0.82 +/- 0.02 g/cm) or had persistent amenorrhea and hyperprolactinemia (0.81 +/- 0.02 g/cm). Serum estradiol concentrations did not differ significantly in the four groups, and there was no correlation between estradiol concentration and bone mineral content or between PRL concentration and bone mineral content in the amenorrheic women. The presence of decreased bone mineral content in hyperprolactinemic patients suggests that PRL may have a direct effect on bone and may be another indication for early treatment of PRL-secreting pituitary tumors.


This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
A. M. Meaney, S. Smith, O. D. Howes, M. O'brien, R. M. Murray, and V. O'keane
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia
The British Journal of Psychiatry, June 1, 2004; 184(6): 503 - 508.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
W. Chowanadisai, S. L. Kelleher, and B. Lonnerdal
Maternal Zinc Deficiency Raises Plasma Prolactin Levels in Lactating Rats
J. Nutr., June 1, 2004; 134(6): 1314 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Coss, L. Yang, C. B. Kuo, X. Xu, R. A. Luben, and A. M. Walker
Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat
Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1216 - E1225.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
U. Fahy, M.I. Hopton, M. Hartog, C.H. Bolton, and M.G.R. Hull
The lipoprotein profile of women with hyperprolactinaemic amenorrhoea
Hum. Reprod., February 1, 1999; 14(2): 285 - 287.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Di Somma, A. Colao, A. Di Sarno, M. Klain, M. L. Landi, G. Facciolli, R. Pivonello, N. Panza, M. Salvatore, and G. Lombardi
Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 807 - 813.
[Abstract] [Full Text]


Home page
Am J Sports MedHome page
S. D. Cook, A. F. Harding, K. A. Thomas, E. L. Morgan, K. M. Schnurpfeil, and R. J. Haddad JR
Trabecular bone density and menstrual function in women runners
Am. J. Sports Med., September 1, 1987; 15(5): 503 - 507.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society